These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 38446328)

  • 1. Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target.
    Olejnik P; Buczma K; Cudnoch-Jędrzejewska A; Kasarełło K
    Immunol Res; 2024 Aug; 72(4):554-565. PubMed ID: 38446328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the gut to treat multiple sclerosis.
    Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
    Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
    Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
    Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
    Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
    Camara-Lemarroy CR; Metz LM; Yong VW
    World J Gastroenterol; 2018 Oct; 24(37):4217-4223. PubMed ID: 30310254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
    Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Microbial Metabolites in the Progression of Neurodegenerative Diseases-Therapeutic Approaches: A Comprehensive Review.
    Missiego-Beltrán J; Beltrán-Velasco AI
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-chain fatty acids and gut microbiota in multiple sclerosis.
    Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
    Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
    Kumar N; Sahoo NK; Mehan S; Verma B
    Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
    Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
    Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of microbiome metabolites on immune regulation and autoimmunity.
    Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
    Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Intestinal Microbiota and Probiotics Supplementation in Multiple Sclerosis Management.
    Hasaniani N; Mostafa Rahimi S; Akbari M; Sadati F; Pournajaf A; Rostami-Mansoor S
    Neuroscience; 2024 Jul; 551():31-42. PubMed ID: 38777135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second brain: The connection between gut microbiota composition and multiple sclerosis.
    Farshbafnadi M; Agah E; Rezaei N
    J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.
    Dziedzic A; Saluk J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.